User profiles for Jane Armitage

Jane Armitage

Professor of Clinical Trials and Epidemiology
Verified email at ndph.ox.ac.uk
Cited by 20887

[HTML][HTML] Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

…, J Carrie, J Rojas, S Amoils, J Bamford, J Armitage… - The Lancet, 2019 - thelancet.com
Background Antiplatelet therapy reduces the risk of major vascular events for people with
occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. …

A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease

…, P Eriksson, A Offer, L Bowman, P Sleight, J Armitage… - Nature …, 2011 - nature.com
Genome-wide association studies have identified 11 common variants convincingly associated
with coronary artery disease (CAD) 1 , 2 , 3 , 4 , 5 , 6 , 7 , a modest number considering …

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.

J Armitage, L Bowman, K Wallendszus… - Lancet (London …, 2010 - ora.ox.ac.uk
Background Lowering of LDL cholesterol reduces major vascular events, but whether more
intensive therapy safely produces extra benefi ts is uncertain. We aimed to establish effi cacy …

[HTML][HTML] Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

…, K Davies, H Halls, L Holland, K Wilson, J Armitage… - The Lancet, 2022 - thelancet.com
Background Statin therapy is effective for the prevention of atherosclerotic cardiovascular
disease and is widely prescribed, but there are persisting concerns that statin therapy might …

[HTML][HTML] The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a …

…, R Grimm, T Pedersen, J Tobert, J Armitage… - The Lancet, 2011 - thelancet.com
Background Lowering LDL cholesterol with statin regimens reduces the risk of myocardial
infarction, ischaemic stroke, and the need for coronary revascularisation in people without …

[HTML][HTML] Interpretation of the evidence for the efficacy and safety of statin therapy

R Collins, C Reith, J Emberson, J Armitage, C Baigent… - The Lancet, 2016 - thelancet.com
This Review is intended to help clinicians, patients, and the public make informed decisions
about statin therapy for the prevention of heart attacks and strokes. It explains how the …

Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease

W Herrington, B Lacey, P Sherliker, J Armitage… - Circulation …, 2016 - Am Heart Assoc
Atherosclerosis is a leading cause of vascular disease worldwide. Its major clinical manifestations
include ischemic heart disease, ischemic stroke, and peripheral arterial disease. In …

The safety of statins in clinical practice

J Armitage - The Lancet, 2007 - thelancet.com
Statins are effective cholesterol-lowering drugs that reduce the risk of cardiovascular disease
events (heart attacks, strokes, and the need for arterial revascularisation). Adverse effects …

Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individuals

…, J Bosch, R Collins, S Lewington, J Armitage… - JAMA …, 2018 - jamanetwork.com
Importance Current guidelines advocate the use of marine-derived omega-3 fatty acids
supplements for the prevention of coronary heart disease and major vascular events in people …

[HTML][HTML] Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

J Armitage, C Baigent, E Barnes, DJ Betteridge… - The Lancet, 2019 - thelancet.com
Background Statin therapy has been shown to reduce major vascular events and vascular
mortality in a wide range of individuals, but there is uncertainty about its efficacy and safety …